1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Minnesota >
  6. Surgalign Acquires Zyga Technology

M&A Deal Summary

Surgalign Acquires Zyga Technology

On January 4, 2018, Surgalign acquired medical products company Zyga Technology

Acquisition Highlights
  • This is Surgalign’s 3rd transaction in the Medical Products sector.
  • This is Surgalign’s 3rd transaction in the United States.
  • This is Surgalign’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2018-01-04
Target Zyga Technology
Sector Medical Products
Buyer(s) Surgalign
Deal Type Add-on Acquisition

Target

Zyga Technology

Minnetonk, Minnesota, United States
Zyga Technology, Inc. is a spine-focused medical device company that develops and produces innovative minimally invasive devices to treat underserved conditions of the lumbar spine. Zyga Technology was founded in 2008 and is based in Minnetonk, Minnesota.

Search 215,074 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Surgalign

Deerfield, Illinois, United States
Category Company
Founded 1997
Sector Medical Products
Employees200
Revenue 102M USD (2020)
DESCRIPTION

Surgalign is a medical technology company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes. The company is building off a legacy of high quality and differentiated products and continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient’s lives. Surgalign was formed in 1997 and is based in Deerfield, Illinois.

DEAL STATS #
Overall 3 of 5
Sector: Medical Products M&A 3 of 5
Type: Add-on Acquisition M&A Deals 2 of 4
State: Minnesota M&A 1 of 1
Country: United States M&A 3 of 5
Year: 2018 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-03 RTI Surgical - Cardiothoracic Closure Business

Alachua, Florida, United States

RTI Surgical, Inc. - Cardiothoracic Closure Business engages in manufacturing of products and the engineering, development and manufacturing of potential future products. The cardiothoracic closure business was one of several components of Pioneer® Surgical Technology.

Sell $60M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-01 Paradigm Spine

New York, New York, United States

Paradigm Spine is a company focused on the design and development of solutions for the disease management of spinal stenosis. The company's signature product is the coflex Interlaminar Stabilization device. Coflex is the only lumbar spinal device that has produced Level I evidence in two separate prospective, randomized, controlled studies against two different surgical control groups, changing the standard of care for lumbar spinal stenosis treatment. Paradigm Spine is based in New York, New York.

Buy $300M
Mergr

Solution for

Product

Company

Legal